Daguang Wang


Daguang Wang joined Yonjin Venture in June 2018 as a managing director. He has close to 20 years’ experience in research and development and business development in both large and small biopharmaceutical companies.

Daguang serves on the board of Evasc, Hyperfine Research, MetaboMed, Regenacy Pharmaceuticals, EvolveImmune Therapeutics, Libra The...

Roles at OncoResponse

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.